Study indicates a very high level of resilience among Canadians with arthritis

The FDA on Tues­day ap­proved Idor­sia’s new treat­ment for pa­tients with high blood pres­sure who aren’t ad­e­quate­ly treat­ed by cur­rent med­ica­tions. But the drug comes

The FTC on Mon­day filed an am­i­cus brief in My­lan Phar­ma­ceu­ti­cals’ an­titrust law­suit al­leg­ing that Sanofi abused the FDA’s Or­ange Book to de­lay and block

Af­ter a year of nav­i­gat­ing “shift­ing mar­ket dy­nam­ics,” Lon­za re­port­ed on Fri­day it had a 7.9% sales rev­enue in­crease for 2023 com­pared to the pre­vi­ous